Authors

  • Siddikov A.M.

Keywords:

myocardial reperfusion damage, IL-6, TNF-α, Fas ligand, HMGB1, troponin, artificial circulation, prognosis.

References

Atayev Sh. A., Hojiyev B. F., Abdullayev Sh. M. Immunological markers of myocardial reperfusion damage in children after heart surgeries. // Bulletin of Cardiac Surgery. - 2022. - Vol. 34, No4. - P. 56-63.

Gerasimenko S. Yu., Kuznetsov I. A. Inflammatory response in cardiac surgery and ways to correct it. - Moscow: GEOTAR-Media, 2021. - 236 p.

Davydov V. A., Lipatov A. V. Cytokine profile in reperfusion lesions: clinical significance. // Russian Cardiology Journal. - 2020. - No11. - P. 15-22.

Hojiyev B. F., Rakhimov I. B. Features of the systemic inflammatory response in children during heart surgeries under IR conditions. // Medical Journal of Uzbekistan. - 2023. - No2. - P. 48-55.

Parkhomenko A. N., Kozhukhov S. N. Myocardial reperfusion damage: pathogenesis and modern approaches to therapy. - Kiev: Health, 2020. - 178 p.

I., Zurko V. A. Cytokines and apoptosis in the pathogenesis of reperfusion complications. // Immunology. - 2021. - Vol. 42, No. 3. - P. 19-28.

Watanabe Y., Nishiyama M., Okamoto K. Immunoregulatory cytokines and myocardial reperfusion injury after cardiopulmonary bypass. // Clinical Immunology. - 2021. - Vol. 226. - P. 109-116.

Zhang L., Chen Y., Huang W. The role of TNF-α and IL-6 in myocardial ischemia-reperfusion injury: mechanisms and clinical implications. // Journal of Cardiology Research. - 2022. - Vol. 15, No. 5. - P. 407-416.

Li X., Zhao Z., Wang J. High-mobility group box-1 (HMGB1) and apoptosis pathways in reperfusion injury after cardiac surgery. // Experimental and Therapeutic Medicine. - 2023. - Vol. 25, No. 2. - P. 214-223.

World Health Organization. Global health assessments 2024: Mortality and causes of death by country, age and sex, 2000-2023. - Geneva: WHO, 2024. - 180 p.